Exactly, and as per a previous screen shot in a previous chat, ATH 434 has been provided too another professor to utilise ATH434 in dementia research, and if successful, Alterity gains royalties.
And yes, although it doesnt specifically discuss MSA or PD, the mechanism of what Alterity is attempting to achieve, via iron redistribution, is exactly what the video discusses, thus breaking the iron aggregation link and preventing neuron degradation and resukts that follow.
I think the educational video will/should put more hope into this trial...well it did for me.
I also read something earlier today, which I was going to either screen shot or copy the link, but I had to cross reference it, than i got distracted. If i remember, ill go back and have a look, it was around specific drugs that chelate with excess iron in the body which is specifically approved by FDA, obviously one being the chemical compounds within ATH434.
ATH Price at posting:
0.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)